JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB62352

Anti-Nrf2 antibody [EP1808Y]

4

(34 Reviews)

|

(799 Publications)

Anti-Nrf2 antibody [EP1808Y] (ab62352) is a rabbit monoclonal antibody detecting Nrf2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, ICC/IF. Suitable for Human.

- Clone EP1808Y is the most cited clone to Nrf2
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 580 publications

View Alternative Names

NRF2, NFE2L2, Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2

10 Images
Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • WB

Lab

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)

False colour image of Western blot : Anti-Nrf2 antibody [EP1808Y] - ChIP Grade staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab62352 was shown to bind specifically to Nrf2.

Target band (indicated by arrow) was observed at 85-90 kDa in wild-type A549 cell lysates with no signal observed at this size in NFE2L2 knockout cell line ab285359 (knockout cell lysate ab289682). A band lower than the target was present on both WT and KO. According to the literature (PMID : 40043449), the lower band is calmegin.

To generate this image, wild-type and NFE2L2 knockout A549 cell lysates were analysed. Please note that MG132 treatment does not affect expression levels of Nrf2. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/1000 dilution

Lane 1:

Wild-type A549 Vehicle control MG132 (0 uM, 18 h) cell lysate at 20 µg

Lane 2:

Wild-type A549 Treated MG132 (2 uM, 18 h) cell lysate at 20 µg

Lane 3:

NFE2L2 [21] knockout A549 Vehicle control MG132 (0 uM, 18 h) cell lysate at 20 µg

Lane 4:

NFE2L2 [21] knockout A549 Treated MG132 (2 uM, 18 h) cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 68 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)

ab62352 staining Nrf2 in untreated wild type A549 cells (left panel), treated wild type A549 cells (middle panel) and untreated NFE2L2 knockout A549 cells (right panel). Cells were treated with 2µM of MG-132 for 18 hours (ab141003). The cells were fixed with 4% paraformaldehyde (10 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab62352 at 0.2 µg/ml concentration and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2µg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2µg/ml (shown in magenta). Nuclear DNA was labelled in blue with DAPI.

Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)

Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labelling Nrf2 with ab62352 at 1/40 (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. An Alexa Fluorr®488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Nrf2 antibody [EP1808Y] (AB62352)

Intracellular Flow Cytometry analysis of HeLa cells labelling Nrf2 with purified ab62352 at a dilution of 1/60 (red). Cells were fixed with 4% paraformaldehyde. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG (ab172730). Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)

ab62352 staining Nrf2 in untreated HeLa cells (top panel) and treated HeLa cells (bottom panel). Cells were treated with 2μM of MG-132 for 18 hours (ab141003). The cells were fixed with 4% paraformaldehyde (10 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab62352 at 1μg/ml concentration and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)

Immunocytochemistry/Immunofluorescence analysis of HepG2 cells labelling Nrf2 with purified ab62352 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. The cells were co-stained with ab195889, an Alexa Fluor® 594-conjugated mouse anti-alpha tubulin antibody (1/200). Nuclei counterstained with DAPI (blue).

Secondary antibody only control : PBS was used instead of the primary antibody as the negative control.

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Nrf2 antibody [EP1808Y] (AB62352)

Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling Nrf2 with purified ab62352 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (1/1000) was used as the secondary antibody. Cells were counterstained with ab195889, anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594). DAPI was used to stain the nuclei blue.

Secondary antibody only control : PBS was used instead of the primary antibody as the negative control.

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • WB

Lab

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)

False colour image of Western blot : Anti-Nrf2 antibody [EP1808Y] - ChIP Grade staining at 1/500 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab62352 was shown to bind specifically to Nrf2. A band was observed at 85 kDa in wild-type HeLa cell lysates with no signal observed at this size in NFE2L2 knockout cell line ab262507 (knockout cell lysate ab263934). The band observed in the knockout lysate lane below 85 kDa is likely to represent a truncated form of Nrf2. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and NFE2L2 knockout HeLa cell lysates were analysed.First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/500 dilution

Lane 1:

Western blot - Human NFE2L2 (Nrf2) knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-nfe2l2-nrf2-knockout-hela-cell-lysate-ab263934'>ab263934</a>)

Lane 1:

Wild-type HeLa control MG132 (0 uM, 18 h) cell lysate

Lane 2:

Wild-type HeLa treated MG132 (2 uM, 18 h) cell lysate

Lane 2:

Western blot - Human NFE2L2 (Nrf2) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-nfe2l2-nrf2-knockout-hela-cell-line-ab262507'>ab262507</a>)

Lane 3:

NFE2L2 knockout HeLa control MG132 (0 uM, 18 h) cell lysate

Lane 4:

NFE2L2 knockout HeLa treated MG132 (2 uM, 18 h) cell lysate

Lane 5:

HCT 116 cell lysate

false

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • WB

Lab

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)

The expression of Nrf2 is stimulated by oxidative stress, electrophiles and chemical activators (PMID : 25761198, PMID : 27638861 and PMID : 28587109). ab62352 detects no signal in most of the untreated samples in WB. Stimuli treated samples are recommended.

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/200 dilution

Lane 1:

HCT 116 (Human colorectal carcinoma epithelial cell) whole cell lysates at 20 µg

Lane 2:

HCT 116 (Human colorectal carcinoma epithelial cell) treated with 25uM MG-132 for 4 hours whole cell lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 68 kDa

Observed band size: 100 kDa

false

Exposure time: 60s

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)
  • WB

AbReview81245****

Western blot - Anti-Nrf2 antibody [EP1808Y] (AB62352)

Western blot analysis using ab62352 at 1 : 1000 on Human iPSC-cardiomyocytes. Blocking agent and dilution buffer was 5% Skim Milk in TBS-Tween.

A cellular fractionation in Human iPSC-cardiomyocyte cells was performed to separate the nucleus from the cytoplasm (Lane 2).

All lanes:

Western blot - Anti-Nrf2 antibody [EP1808Y] (ab62352) at 1/1000 dilution

Lane 1:

Human iPSC-cardiomyocytes cytoplasmatic fraction, at 20 µg

Lane 2:

Human iPSC-cardiomyocytes nuclear fraction at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab6721'>ab6721</a>) at 1/2000 dilution

Observed band size: 100 kDa

false

  • 578 PE

    PE Anti-Nrf2 antibody [EP1808Y]

  • 660 APC

    APC Anti-Nrf2 antibody [EP1808Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Nrf2 antibody [EP1808Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Nrf2 antibody [EP1808Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Nrf2 antibody [EP1808Y]

  • Carrier free

    Anti-Nrf2 antibody [EP1808Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1808Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt (Intra), ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The expression of Nrf2 is stimulated by oxidative stress, electrophiles and chemical activators (PMID: 25761198, PMID: 27638861 and PMID: 28587109). Nrf2 antibody (ab62352) detects no signal in most untreated samples in WB. Stimuli treated samples are recommended. We do not recommend using this product in western blot with tissue lysates, however some customers have used this antibody successfully using concentrated samples (see submitted abreviews).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p></p>", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/200 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000 - 1/5000", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/40", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Anti-Nrf2 antibody [EP1808Y] (ab62352) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF and WB.

Anti-Nrf2 antibody [EP1808Y] (ab62352) was first used in a scientific publication in 2009 and has been cited over 584 times in peer reviewed journals. It's performance in Western Blot in human samples is trusted by the scientific community.

Abcam's high quality manufacturing and validation processes ensure Anti-Nrf2 antibody [EP1808Y] (ab62352) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

The specificity of Anti-Nrf2 antibody [EP1808Y] (ab62352) has been confirmed by Western Blot testing in Nrf2 knockout HeLa cells (ab262507).

Anti-Nrf2 antibody [EP1808Y] (ab62352) has 28 independent reviews from customers.

Anti-Nrf2 antibody [EP1808Y] (ab62352) specifically detects Nrf2 (UniProt ID: Q16236; Molecular weight: 68kDa) and is sold in 100 µL and 1 mL selling sizes.

Conjugation-ready, carrier free format available for antibody clone EP1808Y - ab180845.

Antibody clone EP1808Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 594, PE, APC (ab194984, ab194985, ab206890, ab223926, ab223927).

NRF2 is a pivotal transcription factor in neuro research, known for regulating cellular defense mechanisms. It supports mitochondrial function and protects against oxidative damage, which is crucial for brain health. NRF2 also modulates glial inflammatory responses, playing a significant role in preventing neuroinflammation. Researchers use NRF2 to study oxidative stress, inflammation and neuroprotection, making it essential for understanding and potentially treating neurodegenerative diseases.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nrf2 also known as nuclear factor erythroid 2-related factor 2 is a transcription factor with a molecular weight of approximately 66 kDa. It plays a mechanical role in regulating the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. Nrf2 is ubiquitously expressed in various tissues including the liver lungs and skin. Nrf2 activation occurs when it translocates from the cytoplasm to the nucleus to bind the antioxidant response element (ARE) in the DNA starting transcription of target genes.
Biological function summary

Nrf2 acts as an important regulator of the cellular antioxidant response. It works in conjunction with its partner protein Keap1 forming a complex that controls its stability and degradation. Under normal conditions Keap1 keeps Nrf2 in the cytoplasm where it is targeted for ubiquitination and degradation. Once activated by oxidative stress or electrophiles Nrf2 dissociates from Keap1 thereby avoiding degradation and relocates to the nucleus to activate the transcription of ARE-dependent genes. This activity boosts the cellular response to oxidative stress by inducing genes involved in detoxification and cellular defense.

Pathways

Nrf2 plays a significant role in the oxidative stress response and detoxification pathways. Nrf2 activation is linked closely to the PI3K/Akt signaling pathway which influences cell survival growth and metabolism. This pathway also interacts with other important proteins like GSK-3β which can modulate Nrf2 activity and stability. Through these pathways Nrf2 orchestrates a defense mechanism against reactive oxygen species (ROS) by boosting the expression of antioxidant enzymes and detoxifying proteins.

Nrf2 has been associated with conditions like cancer and neurodegenerative diseases. In cancer aberrant Nrf2 activation may lead to enhanced tumor survival by increasing expression of cytoprotective genes which makes cancer cells resistant to chemotherapy. Nrf2 also interacts with proteins such as p53 which play roles in tumor suppression and cellular stress responses. In neurodegenerative disorders reduced Nrf2 activity can contribute to oxidative stress leading to neuron damage and disease progression with proteins like amyloid-beta also being linked with oxidative processes affected by Nrf2 functionality.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the NFE2L2 gene functions as a transcription factor that plays a key role in responding to oxidative stress by binding to antioxidant response elements (ARE) in the promoter regions of various cytoprotective genes, such as phase 2 detoxifying enzymes, to promote their expression and neutralize reactive electrophiles. Under normal conditions, it is ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex. However, oxidative stress leads to the inhibition of the BCR(KEAP1) complex, allowing NFE2L2/NRF2 to accumulate in the nucleus, form heterodimers with small Maf proteins, and bind to ARE elements. Additionally, the NFE2L2/NRF2 pathway is activated by selective autophagy, where KEAP1 interacts with SQSTM1/p62, inactivating the BCR(KEAP1) complex and leading to nuclear NFE2L2/NRF2 accumulation and cytoprotective gene expression. It may also be involved in activating genes of the beta-globin cluster by facilitating enhancer activity of hypersensitive site 2 of the beta-globin locus control region. This supplementary information is collated from multiple sources and compiled automatically.
See full target information NFE2L2

Publications (799)

Recent publications for all applications. Explore the full list and refine your search

European journal of histochemistry : EJH 69: PubMed41036671

2025

Guilu Erxian oral liquid mitigates oxidative damage in spermatogonial cells miR-6739-5p modulation and PI3K/AKT pathway activation: a functional histocytochemical study.

Applications

Unspecified application

Species

Unspecified reactive species

Zefeng Sun,Xinrong Fan,Zhenquan Liu

Journal of ovarian research 18:213 PubMed41029755

2025

NRF2 promotes the migration of ovarian cancer cell lines by targeting TAGLN mediated epithelial-mesenchymal transition.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wang,Panpan Zhang,Qi Cheng,Lingjie Bao

Nucleic acids research 53: PubMed41020501

2025

Stable Cas9 expression regulates cell growth by facilitating mTORC2 activation.

Applications

Unspecified application

Species

Unspecified reactive species

Le Yu,Yi Jin,Jianfeng Chen,Zhichuan Zhu,Siyuan Su,Emily M Wilkerson,Joanna Gongora,Erica W Cloer,Michael B Major,Pengda Liu

Mediators of inflammation 2025:4932970 PubMed40918406

2025

Electroacupuncture Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating the Esr1/TAK1-JNK/p38 Signaling Pathway in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofang Fan,Wei Guo,Xiaodan Yang,Hao Zhang,Bruno Fink,Lingyu Hu,Xiaoguang Wang

Medical oncology (Northwood, London, England) 42:456 PubMed40883565

2025

Wedelolactone induces pyroptosis to suppress retinoblastoma by inhibiting the Nrf2/Keap1 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yizhou Jiang,Hua Jiang,Guitao Wu,Ningdong Pang,Chuanqiang Niu,Zhouping Wang,Haibo Li

Clinical, cosmetic and investigational dermatology 18:1971-1983 PubMed40860313

2025

Ellagic Acid Mediates the Delay of Dermal Fibroblast Senescence via CSNK2A1.

Applications

Unspecified application

Species

Unspecified reactive species

Ziwei Zhang,Pu Yang,Yang Sun,Xinhai Yu,Xiangyu Chen,Xiancheng Wang

Orphanet journal of rare diseases 20:453 PubMed40849475

2025

Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia.

Applications

Unspecified application

Species

Unspecified reactive species

Marta Talaverón-Rey,Diana Reche-López,Suleva Povea-Cabello,Mónica Álvarez-Córdoba,David Gómez-Fernández,Ana Romero-González,Paula Cilleros-Holgado,José Manuel Romero-Domínguez,Alejandra López-Cabrera,Rocío Piñero-Pérez,Susana González-Granero,José Manuel García-Verdugo,José A Sánchez-Alcázar

Cell death discovery 11:380 PubMed40813365

2025

Targeting hypoxia-inducible factor-1 in a hypoxidative stress model protects retinal pigment epithelium cells from cell death and metabolic dysregulation.

Applications

Unspecified application

Species

Unspecified reactive species

Annika Schubert,Maria Eduarda Lobo Barbosa da Silva,Tabea Ambrock,Orbel Terosian,Anna Malyshkina,Claudia Padberg,Safa Larafa,Johann Matschke,Joachim Fandrey,Yoshiyuki Henning

Cell death & disease 16:616 PubMed40796730

2025

The ALDH2/PolG2 axis enhances mitochondrial biogenesis via transcriptional regulation of Nrf2 and promotes chemotherapy resistance in acute myeloid leukaemia.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuying Hu,Tianzhen Hu,Shuyun Cao,Li Jiang,Yan Zhou,Qin Fang,Jishi Wang

Journal of clinical biochemistry and nutrition 77:30-36 PubMed40777822

2025

Kurarinone activates the Nrf-2/HO-1 signaling pathway and alleviates high glucose-induced ferroptosis in HK2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Chunmei Ma
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com